Hands-on learning has recently paid off for several Hiram College alumni. Since late 2007, several Hiram undergraduates have worked with Ganeden Biotech, a probiotics company in Mayfield Heights. Ganeden Biotech’s probiotic strain was recently given Food and Drug Administration approval to be the first probiotic in the U.S. to be published in the U.S. Pharmacopeial Convention, a scientific nonprofit organization that sets standards for the identity, strength, quality and purity of medicines, food ingredients and dietary supplements.
Ganeden Biotech produces GanedenBC30, a spore-forming Bacillus coagulans strain that is used as a probiotic food supplement in a wide variety of human and companion animal food products. Under the supervision of Brad Goodner, professor of biology at Hiram College, these students have been working to help develop the genetic methods to distinguish GanedenBC30 from other probiotic bacteria. Students that have been involved in this over the years include Ann Dombroski ‘10, Hannah Petcovic ‘12, Gurneet Raina ‘13, who also did a summer internship with Ganeden, and Recebba Roemer ‘08 who worked for Ganeden as a laboratory technician for three years after graduating from Hiram College.
“Figuring out how to identify this organism compared to others turned out to be tougher than we thought,” said Goodner, “but it was a fantastic experience for my students to collaborate with great corporate scientists and executives. The fact that Ganeden Biotech is a company in Northeast Ohio made it that much more special.”
For more information on this announcement, please visit: http://www.ganedenbiotech.com/probiotic-news/news_releases/usp-issues-testing-standards-monograph-for-ganedenbc30.
[btn link=”http://www.hiram.edu/biology” color=”grey” size=”size-m”]Learn more about biology at Hiram College.[/btn]